Literature DB >> 7779292

Effects of short-term transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer's disease.

E J Scherder1, A Bouma, A M Steen.   

Abstract

The present study investigated whether a 30-minute-a-day transcutaneous electrical nerve stimulation (short-term TENS) might improve disturbances in memory and affective behaviour in patients with probable Alzheimer's disease. The hypothesis was derived from former studies in which beneficial effects on memory and affective behaviour of Alzheimer patients were found after a daily application of 6-h TENS and a 30-min tactile stimulation. The present data reveal that short-term TENS improved some aspects of verbal and visual short-term and long-term memory. Moreover, patients who had undergone this treatment felt, e.g., less dejected, less gloomy, less irritable, more cheerful, more active, and more alert. They were also more interested in social contacts and participated more in daily activities. After a period of 6 weeks following treatment, the effects on memory as well as the improvements in affective behaviour partially remained.

Entities:  

Mesh:

Year:  1995        PMID: 7779292     DOI: 10.1016/0166-4328(94)00115-v

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  4 in total

Review 1.  Massage and touch for dementia.

Authors:  N Viggo Hansen; T Jørgensen; L Ørtenblad
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 2.  Transcutaneous electrical nerve stimulation (TENS) for dementia.

Authors:  M Cameron; E Lonergan; H Lee
Journal:  Cochrane Database Syst Rev       Date:  2003

3.  Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects.

Authors:  Maxime Piquet; Costantino Balestra; Simona L Sava; Jean E Schoenen
Journal:  BMC Neurol       Date:  2011-10-28       Impact factor: 2.474

Review 4.  Brain Stimulation in Alzheimer's Disease.

Authors:  Chun-Hung Chang; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Front Psychiatry       Date:  2018-05-22       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.